MARK RYAN: Open Payments
NPI 1659513919 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,841 in 106 payments from 24 companies in 2025. Trend: 2023 $1,161 · 2024 $1,914 · 2025 $1,841
Food & beverage: $1,841
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $322 |
| Novo Nordisk Inc | 15 | $201 |
| Lilly USA, LLC | 13 | $190 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Amgen Inc. | 9 | $137 |
| ABBVIE INC. | 5 | $99 |
| Corcept Therapeutics | 3 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $86 |
| Exact Sciences Corporation | 4 | $80 |
| Corium, LLC | 2 | $63 |
Products named: NURTEC ODT, Wegovy, MOUNJARO, Korlym, XIFAXAN, PREVNAR 20, EVENITY, JARDIANCE.
Industry payments across FL — which companies pay providers there.
